GlassScriptPhysician profile
Matthew G Gentry
NPI 1558654913
$7,850.09
in general payments reported to CMS, 2019-2025
56 companies · $2,435 in 2025
The $2,435 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $831 · 2021: $1,246 · 2022: $846 · 2023: $679 · 2024: $1,014 · 2025: $2,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,040 · Education: $87.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,039.93 |
| Education | $87.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $792.69 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $637.72 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $583.96 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $554.57 | 2025 | Ponvory |
| Mdd US Operations, LLC | $393.82 | 2020-2025 | Apokyn, Apokyn |
| Harmony Biosciences LLC | $375.89 | 2020-2025 | |
| Genzyme Corporation | $370.34 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $290.30 | 2019-2024 | |
| Argenx US, INC. | $279.59 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $274.16 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $254.37 | 2020-2025 | Austedo Xr, Austedo Xr, Austedo |
| Alexion Pharmaceuticals, INC. | $222.43 | 2020-2025 | Ultomiris |
| Ucb, INC. | $207.87 | 2019-2025 | Briviact |
| Celgene Corporation | $147.85 | 2021-2025 | Zeposia |
| Tanabe Pharma America, INC. | $145.33 | 2021-2025 | Radicava |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gentry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.